Skip to main content
BDRX logo

BDRX

Compare

Biodexa Pharmaceuticals Plc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Values in USD · ADR · Reports in GBP

Historical stock prices for MLP & Strategic Equity Fund Inc. (MTP). MLP & Strategic Equity Fund Inc. (the Fund) is a closed-end management investment company. The Fund's investment objective is to provide a high level of after-tax total return. The Fund pursues its investment objective by investing substantially all of its net assets in publicly traded master limited partnerships (MLPs) operating in the energy infrastructure sector of the market. The Fund may purchase both domestic and international MLPs. The Fund's investment in MLPs may include ownership of MLP common units and MLP subordinated units. The Company invests in industries include oil and gas storage, oil gas explore, coal-consumfuel, gas utilities and oil gas refine. The Fund also may purchase MLP I-Shares (together with the MLPs, the MLP Entities). Nuveen Fund Advisors, Inc. is the Fund's advisor. On August 27, 2012, the Company merged with Nuveen Energy MLP Total Return Fund.

Current Price

Profile
Valuation (TTM)
Market Cap
P/E
EV
P/B
Shares Out
P/Sales
Revenue
EV/EBITDA

Biodexa Pharmaceuticals Plc (BDRX) Financial Statements

Values in USD · ADR · Reports in GBP

BDRX Financial Data

EBITDA
Revenue (TTM)
Gross Profit (TTM)
Gross Margin
Operating Margin
ROE
ROA
Debt/Equity
Current Ratio
FCF
FCF Yield
Piotroski F-Score
Rev/Share (TTM)
50-Day MA
200-Day MA
Shares Outstanding

BDRX Computed Insights

FCF
FCF Growth Rate
EPS Growth (CAGR)
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

BDRX Financial Statements & Data

Biodexa Pharmaceuticals Plc (BDRX) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Biodexa Pharmaceuticals Plc's financial performance and position as a Healthcare company.

Weighted average cost of capital (WACC) is 10.00%.

GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Biodexa Pharmaceuticals Plc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.